A Point Mutation in an Invariant Splice Acceptor Site Results in a Decreased mRNA Level in a Patient with Severe Coagulation Factor XIII Subunit A Deficiency

Summary

Amplification and sequencing of exons I-XV of the gene encoding subunit A of coagulation factor XIII (FXIII) in a patient with severe subunit A deficiency revealed a single G → A base substitution at the last position of intron E, mutating the invariant AG dinucleotide splice acceptor site to AA. Northern blot analysis of FXIII subunit A mRNA levels in peripheral mononuclear leukocytes showed that this mutation leads to an undetectable FXIII subunit A mRNA level, suggesting that the mutant transcript is either highly unstable or only spliced at low efficiency. Despite this low mRNA level we were able to amplify cDNA fragments containing the exonV-exonVI junction. Sequence analysis showed that the AA dinucleotide is not recognized by the splicing machinery. Instead, an AG dinucleotide located seven bases downstream of the mutated splice acceptor site is used as alternative acceptor. The resulting, alternatively spliced, FXIII subunit A transcript contains a deletion of the first seven bases of exon VI, while translation continues out of frame and leads to a premature stop codon 27 bases thereafter.

• References

• 1 Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1395-2407
• 2 Board PG, Webb GC, McKee J, Ichinose A. Localization of the coagulation factor XIIIA subunit gene to chromosome bands 6p24 → 25. Cytogenet Cell Genet 1988; 48: 25-27
• 3 Webb GC, Coggan M, Ichinose A, Board PG. Localization of human coagulation factor XIIIB subunit gene to chromosome band lq31-32.1 and restriction fragment polymorphism of the locus. Hum Genet 1989; 81: 157-160
• 4 Lorand L, Losowsky MS, Miloszewski KJM. Human factor XIII fibrin- stabilizing factor. Prog Hemost Thromb 1980; 5: 245-290
• 5 Duckert F. Documentation of the human factor XIII deficiency in man. Ann NY Acad Sci 1972; 202: 190-199
• 6 Mary A, Achyuthan KE, Greenberg CS. B-chains prevent proteolytic inactivation of the a chains of plasma factor XIII. Biochim Biophys Acta 1988; 966: 328-335
• 7 Miloszewski KJ A, Losowsky MS. Fibrin stabilization and factor XIII deficiency. In: Fibrinogen, Fibrin stabilization and Fibrinolysis. Francis L. ed. Ellis Horwood Ltd; Chichester, England: 1988. pp 175-202
• 8 Tagaki T, Doolittle RF. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry 1974; 13: 750-756
• 9 Ichinose A, Kaetsu H. Molecular approch to structure function relationship of human coagulation factor XIII. Methods Enzymol 1993; 222: 36-51
• 10 Duckert F, Jung E, Schmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 1960; 5: 179-186
• 11 Berliner SH, Lusky A, Zivelin A, Modan M, Seligsohn U. Hereditary factor XIII deficiency: report of four families and definition of the carrier state. Br J Haematol 1984; 56: 495-505
• 12 Kobayashi T, Tereo T, Kojima T, Takamatsu J, Kamiya T, Saito H. Congenital Factor XIII deficiency with treatment of Factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990; 29: 235-238
• 13 Hashiguchi T, Saito M, Morishita E, Matsuda T, Ichinose A. Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. Blood 1993; 82: 145-150
• 14 Saito M, Asakura H, Yosida T, Ito K, Okafuji K, Yosida T, Matsuda T. A familial factor XIII subunit B deficiency. Br J Haematol 1990; 74: 290-294
• 15 Grundmann U, Amann E, Zettlmeissl G, Kupper HA. Characterization of cDNA coding for human factor XHIa. Proc Natl Acad Sci USA 1986; 83: 8024-8028
• 16 Ichinose A, Davie EW. Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 1988; 85: 5829-5833
• 17 Kamura T, Okamura T, Murakawa M, Tsuda H, Teshima T, Shibuya T, Harada M, Niho Y. Deficiency of coagulation factor XIIIA subunit caused by the dinucleotide deletion at the 5’ end of exon III. J Clin Invest 1992; 90: 315-319
• 18 Board PG, Coggan M, Miloszewski K. Identification of a point mutation in Factor XIIIA subunit deficiency. Blood 1992; 80: 937-941
• 19 Standen GR, Bowen DJ. Factor XIIIA Bristol 1: Detection of a point mutation in factor XIIIA subunit deficiency. Br J Haematol 1993; 85: 769-772
• 20 Mikkola H, Syrjälä M, Rasi V, Vahtera E, Hämäläinen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation factor XIII: Two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-525
• 21 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
• 22 Hoar DI. Molecular diagnosis: new horizons in medicine. Can Fam Physician 1987; 33: 401-404
• 23 Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
• 24 Ponte P, Gunning P, Blau H, Kedes L. Human actin genes are single copy for α skeletal and α cardiac actin but multicopy for βand β-cytoskeletal genes: 3’ untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol 1983; 3: 1783-1791
• 25 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Genomics 1977; 5: 463-467
• 26 Barbui T, Rodeghiero F, Dini E, Mariani G, Papa ML, De Biasi R, Cordero Murillo R, Montero Umana C. Subunits A and S inheritance in four families with congenital factor XIII deficiency. Br J Haematol 1978; 38: 267-271
• 27 Weisberg LJ, Shiu DT, Conkling PR, Shuman MA. Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain. Blood 1987; 70: 579-583
• 28 Bookstein R, Shew JY, Chen PL, Scully P, Lee WH. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990; 247: 712-715
• 29 Treisman R, Orkin SH, Maniatis T. Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes. Nature (London) 1983; 302: 591-596
• 30 Atweh GF, Anagnou NP, Shearin J, Forget BG, Kaufman RE. β-Thalassemia resulting from a single nucleotide substitution in a splice acceptor site. Nucl Acids Res 1985; 13: 777-790
• 31 Yoshida K, Yanagisawa N, Oshima A, Sakuraba H, lida Y, Suziki Y. Splicing defect of the glycoasparaginase gene in two Japanese siblings with aspartylglucosaminuria. Hum Genet 1992; 90: 179-180
• 32 Leitcrsdorf E, Reshef A, Meiner V, Levitski R, Schwartz SP, Dann EJ, Berkman N, Cali JJ, Klapholz L, Berginer VM. Frameshift and splice junction mutations in the sterol 27-hydroxylase gene cause eerebrotendinous Xanthomatosis in jews of Moroccan origin. J Clin Invest 1993; 91: 2488-2496
• 33 Soria JM, Fontcubcrta J, Chilión M, Borrell M, Estivill X, Sala N. Acceptor splice site mutation in the invariant AG of intron 5 of the protein C gene, causing type I protein C deficiency. Hum Genet 1993; 92: 506-508
• 34 Lind B, van Solinge WW, Schwatz M, Thorsun S. Splice site mutation in the human protein C gene associated with venous thrombosis: demonstration of exon skipping by ectopic transcript analysis. Blood 1993; 82: 2423-2432
• 35 Senapathy P, Shapiro MB, Harris NL. Splice junctions, branch point sites and exons: sequence statistics, identification and applications to genome project. Meth Enzymol 1990; 183: 252-278
• 36 Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucl Acids Res 1987; 15: 7155-7175
• 37 Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41-54
• 38 Daar IO, Maquat LE. Premature termination of translation mediates triosephosphate isomerase mRNA degradation. Mol Cell Biol 1988; 8: 802-813
• 39 Lim SK, Sigmund CD, Gross KW, Maquat LE. Nonsense codons in human β-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol 1992; 12: 1149-1161
• 40 Herrick D, Parker R, Jacobson A. Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol Cell Biol 1990; 10: 2269-2284
• 41 Cheng J, Maquat LE. Nonsense codons can reduce the abundance of nuelear mRNA without affecting the abundance of pre-mRNA or the halflife of cytoplasmic mRNA. Mol Cell Biol 1993; 13: 1892-1902
• 42 Leeds P, Peltz SW, Jacobson A, Culbertson MR. The product of the yeast UPEI gene is required for rapid turnover of mRNAs containing a premature translational termination codon. Genes Dev 1991; 5: 2303-2314